Feb 16, 2026 3-5pm ET
Monday on The Robert Scott Bell Show:
Hour 1
Ending the Vaccine Carve Out: A Turning Point for Health Freedom and the Autism Community Senator Rand Paul introduced Senate bill S. 3853 to end the vaccine carve out by removing the liability shield for vaccine manufacturers from harms caused by their products, serving as the Senate companion to House bill HR 4668 introduced by Representative Paul Gosar in summer 2025, with support from a coalition including Children’s Health Defense, Teachers for Choice, and over two dozen health freedom organizations. The vaccine carve out was established in 1986 through the National Childhood Vaccine Injury Act, which protects manufacturers from most civil liability claims by redirecting them to the government-run Vaccine Injury Compensation Program rather than allowing direct lawsuits in civil courts. A FabrizioWard poll commissioned by MAHA Action found that ending the liability shield ranks as the most popular vaccine-related policy change across Republicans, Democrats, and Independents, as highlighted in a memo from Tony Lyons to Republican leaders stressing the importance of trust and corporate accountability. For the health freedom movement, this legislation represents a pivotal step toward transparency and accountability by subjecting vaccine manufacturers to the same legal standards as other pharmaceutical companies, without eliminating vaccines, banning any products, or prohibiting recommendations. In the autism community, families frequently raise concerns about potential causation links involving immune dysfunction, gastrointestinal issues, neurological challenges, and environmental triggers or immune stressors, often encountering dismissal when questioning these factors; the author, a mother of a son with autism and founder of Autism Health Inc., views ending the carve out as enabling more rigorous scientific inquiry, restoring transparency in safety science, and giving injured families a meaningful voice in the legal system. Accountability is presented as essential to public health regardless of individual positions on vaccine-autism connections, fostering an environment where safety can be more openly investigated and addressed. The legislation signals a broader cultural shift in which voters increasingly prioritize safety, corporate responsibility, and medical transparency, offering structural reform that empowers individuals, restores dignity to affected families, and aligns with growing demands for evidence-based policy over unchecked industry protections. This development is framed as a turning point that could fundamentally change how vaccine injuries are handled, encouraging manufacturers to prioritize safety innovations and providing a pathway for those harmed to seek redress through traditional civil litigation rather than the no-fault compensation program.
Outrage after US Congress votes to slash $125m in funding to replace toxic lead pipes US Congress voted to redirect $125 million previously allocated for replacing toxic lead service lines in drinking water systems, a cut embedded in a broader government funding bill for fiscal year 2026 that sparked outrage among Democrats, public health advocates, and affected communities, particularly in states like Michigan, Illinois, Texas, and New York with the highest numbers of lead pipes. The funding originated from the 2021 bipartisan Infrastructure Investment and Jobs Act, which provided $15 billion total—$3 billion annually over five years—for lead service line replacements, with the final tranche due for distribution in 2026; Republican leadership on the interior, environment, and related agencies appropriations subcommittee shifted the money to wildfire prevention over Democratic objections, amid simultaneous increases in funding for Immigration and Customs Enforcement. An initial proposal sought a $250 million cut, but House Democrats, led by Representatives Rashida Tlaib and Debbie Dingell, secured a reduction through a letter signed by 43 members emphasizing the public health urgency. Lead exposure has no safe level according to the EPA, causing lowered IQ and developmental delays in children, elevated blood pressure in adults, and potential prevention of up to 900,000 low birth weight cases, 200,000 lost IQ points, and 1,500 premature deaths annually if replacements proceed fully. The 2024 EPA rule mandates complete lead service line replacement within 10 years, but progress remains slow due to utility resistance and massive costs—Chicago alone needs $3 billion for its 400,000 lines, having replaced under 4% so far—while the Trump administration proposed a 90% cut to safe drinking water funding overall and revised EPA estimates downward from 9 million to 4 million lead lines by altering methodology. Advocates including Erik Olson of the Natural Resources Defense Council Action Fund called the redirection “pennywise and poundfoolish,” arguing upfront infrastructure costs pale compared to long-term health and economic burdens, and viewed it as part of broader Republican efforts to undermine the program. Democrats such as Senator Tammy Duckworth labeled the move “obscene” in contrast to boosted ICE allocations, and Tlaib described it as an “insult” to vulnerable communities. The article highlights the cut as a setback in the ongoing battle for clean water access, with no restoration achieved as of publication and concerns that it signals diminished future priorities for lead remediation despite bipartisan origins of the original funding.
Forever Chemicals Triple Risk of Liver Disease in Teens: Study Exposure to per- and polyfluoroalkyl substances (PFAS), known as forever chemicals, more than triples the risk of nonalcoholic fatty liver disease (NAFLD) in adolescents, according to a study published in Environmental Health Perspectives that analyzed data from 1,359 U.S. teens aged 12–19 participating in the National Health and Nutrition Examination Survey between 2017 and 2018. Researchers measured serum levels of seven common PFAS compounds and used ultrasound to assess liver fat content, finding that teens in the highest quartile of combined PFAS exposure had a 3.26 times higher odds of NAFLD compared to those in the lowest quartile after adjusting for age, sex, race/ethnicity, body mass index, poverty-income ratio, physical activity, and dietary factors including sugar-sweetened beverage intake. Individual compounds showed elevated risks as well, with perfluorooctanoic acid (PFOA) linked to 2.85 times higher odds, perfluorooctanesulfonic acid (PFOS) to 2.42 times, and perfluorohexanesulfonic acid (PFHxS) to 2.18 times in the highest exposure groups. The study identified a dose-response relationship where higher cumulative PFAS burdens correlated with progressively greater NAFLD prevalence, with teens in the top exposure quartile exhibiting significantly higher alanine aminotransferase and gamma-glutamyl transferase levels—biomarkers of liver injury—independent of obesity status. NAFLD, characterized by excessive fat accumulation in the liver without alcohol use, affects an estimated 10–20% of U.S. adolescents and is a leading cause of chronic liver disease in youth, progressing in some cases to nonalcoholic steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. PFAS persist indefinitely in the environment and human body due to strong carbon-fluorine bonds, accumulating in blood, liver, and other tissues through contaminated drinking water, food packaging, nonstick cookware, stain-resistant fabrics, and firefighting foam. The authors noted that adolescents may face heightened vulnerability during rapid growth and organ development, with liver metabolism less efficient at clearing these persistent compounds compared to adults. Previous research has linked prenatal and childhood PFAS exposure to metabolic disruptions including insulin resistance and dyslipidemia, which contribute to NAFLD pathogenesis via altered lipid metabolism, inflammation, and oxidative stress in hepatocytes. The findings add to mounting evidence of PFAS hepatotoxicity, including a 2022 National Toxicology Program review classifying PFOA and PFOS as presumed liver toxicants in humans based on consistent associations with elevated liver enzymes and NAFLD across epidemiological studies. The article contextualizes the results amid ongoing regulatory delays, noting the EPA’s 2024 maximum contaminant levels for six PFAS in drinking water but highlighting that many teens continue to face exposures from legacy contamination and consumer products. Authors called for urgent source reduction, stricter limits on PFAS in food contact materials, and expanded biomonitoring to track youth exposure trends, warning that without intervention the rising prevalence of NAFLD in adolescents could impose substantial long-term healthcare burdens from progressive liver disease.
Popular weight loss drugs linked to rare ‘pirate disease’ scurvy, researchers warn Popular GLP-1 receptor agonist medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), widely prescribed for obesity and type 2 diabetes management, have been associated with cases of scurvy—a historically seafaring disease caused by severe vitamin C deficiency—prompting warnings from clinicians that rapid, substantial weight loss induced by these drugs can lead to nutritional shortfalls if patients do not maintain balanced intake of micronutrients. A case series published in the journal Obesity reported three patients who developed clinical scurvy after losing 30–60 pounds over 6–12 months on GLP-1 agonists, presenting with classic symptoms including perifollicular hemorrhages, corkscrew hairs, gingival bleeding, easy bruising, fatigue, joint pain, and poor wound healing; laboratory confirmation showed undetectable or critically low plasma vitamin C levels below 0.2 mg/dL in each case. The patients, all with baseline obesity and no prior history of malnutrition or malabsorption disorders, had drastically reduced caloric intake—often to 800–1,200 calories daily—while prioritizing protein and limiting fruits and vegetables to manage gastrointestinal side effects like nausea, vomiting, and reduced appetite, inadvertently eliminating primary dietary sources of vitamin C such as citrus fruits, bell peppers, strawberries, broccoli, and kiwi. Researchers noted that GLP-1 agonists suppress hunger signals and slow gastric emptying, which can exacerbate avoidance of nutrient-dense foods and contribute to selective eating patterns favoring processed, low-vitamin items. Although scurvy remains rare in developed countries due to widespread vitamin C fortification and availability, the dramatic caloric restriction and behavioral changes induced by these medications create a modern risk profile reminiscent of historical famine or extreme dieting scenarios. The study authors recommend routine nutritional screening, including serum vitamin C measurement, for patients on long-term GLP-1 therapy, particularly those experiencing greater than 15–20% body weight loss or reporting dietary restrictions; they advocate proactive supplementation with a daily multivitamin containing at least 75–90 mg of vitamin C or targeted vitamin C doses of 500–1,000 mg if deficiency is suspected, alongside dietary counseling to incorporate vitamin C-rich foods despite reduced overall intake. Endocrinologists and obesity specialists interviewed emphasized that while these drugs offer substantial cardiometabolic benefits, including improved glycemic control, blood pressure, and lipid profiles, the potential for micronutrient deficiencies—including not only vitamin C but also thiamine, folate, iron, and vitamin B12—underscores the need for multidisciplinary monitoring involving dietitians. The FDA has not issued specific warnings related to scurvy for these agents, but post-marketing surveillance continues to track adverse events, with experts calling for larger cohort studies to quantify the incidence of nutritional deficiencies in real-world GLP-1 users. The article highlights the irony of a treatment designed to combat obesity-related chronic disease potentially introducing an ancient deficiency disorder through unintended dietary consequences, urging patients to discuss nutritional strategies with healthcare providers to mitigate risks while continuing therapy.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
On The Robert Scott Bell Show today, we highlight Ambrosia artemisiaefolia — Rag-Weed.
Boericke presents this remedy as particularly useful in hay-fever, marked by lachrymation, watery coryza, and intolerable itching of the eyelids. It also extends to respiratory obstruction, certain forms of whooping-cough, and summer diarrhoeal conditions, including dysentery.
Download the Information Sheet
Hour 2
Is the MAHA Movement Building a Genuine Counter-Elite? The MAHA movement, emerging from the Covid crisis of 2020–2022, represents a potential genuine counter-elite rooted in common decency as George Orwell described it—the basic virtues of ordinary people that prioritize human dignity over ideological power pursuits—contrasting sharply with the violations during the pandemic when states, media, Big Tech, pharmaceutical companies, and professionals coerced injections into children, restricted livelihoods, and framed such acts as moral imperatives, betraying trust and offending visceral senses of right and wrong. Drawing from Orwell’s 1944 review contrasting E.W. Hornung’s gentleman burglar Raffles, who adhered to unspoken codes against abusing hospitality or murder, with James Hadley Chase’s No Orchids for Miss Blandish, which glorified cruelty and domination, the article argues that Covid-era policies treated bodies as state property and health as a secular religion justifying coercion, such as playground lockdowns, experimental shots, or turning medicine into loyalty tests. Unlike other populist groups like Democratic Socialists of America, MAGA, libertarians, or Catholic integralists, which exhibit a hunger for political power and intoxication with politics, MAHA—coalescing around Robert F. Kennedy Jr.’s 2024 campaign, events like Defeat the Mandate in January 2022 and Rescue the Republic in September 2024, and alliances with medical freedom advocates—refuses to let the body become the “Empire’s final frontier,” rejecting health mandates as licenses for authoritarianism. Philosopher Paul Kingsnorth sees the Covid period as exposing authoritarian tendencies in liberalism through censorship, mass internment justifications, and shifts against liberty, wounding hundreds of millions beyond mere policy errors. Juli Zeh’s 2009 novel The Method depicts a dystopia where health compliance becomes compulsory, mirroring the therapeutic state critiqued by Christopher Lasch and Thomas Szasz, where expansive health definitions enable coercion, as seen in WHO’s broad well-being criteria accelerated during the pandemic. Evidence of MAHA’s distinctiveness includes a Washington, D.C., roundtable where NIH Director Jay Bhattacharya admitted scientific community ethical failures in treating people as biohazards, eroding trust, and proposed a “second scientific revolution” emphasizing replication, repurposed drugs, nutrition, and affordability over novel breakthroughs, delivered in a humble tone that fosters trust. This aligns with anarchist insights and Wendell Berry’s praise of Amish neighborliness as radical embodiment of “Love Thy Neighbor.” The article questions whether MAHA’s decency can endure power acquisition, citing Orwell’s pessimism about politics, but views it as hopeful amid elite discreditation from Epstein revelations, upholding that certain things simply are not done.
Kennedy Allies Target States to Overturn Vaccine Mandates for Schoolchildren Longtime allies of Health and Human Services Secretary Robert F. Kennedy Jr. have formed the Medical Freedom Act Coalition, uniting at least 15 nonprofit organizations to push for the repeal of state laws requiring childhood vaccinations against measles, polio, and other preventable diseases as a condition for entry into day care or kindergarten, with bills introduced in at least nine states including New York, New Hampshire, Georgia, Iowa, and Idaho aiming to eliminate or severely restrict such mandates while preserving limited exemptions. Coalition leaders, including Leslie Manookian—who helped pass Idaho’s law banning medical mandates—have described the 2026 legislative session as an opportunity to “burst the dam open” in receptive states, leveraging perceived federal support from Kennedy’s position to rally grassroots activists and target laws they characterize as coercive medical mandates rather than public health protections. The effort builds on recent federal policy shifts under Kennedy, including reductions in routine childhood vaccine recommendations and changes to ACIP processes, which proponents of immunization view as the first stage in eroding the nation’s vaccine infrastructure. Proponents of maintaining mandates warn that removing school requirements would further dismantle decades-old immunization systems credited with preventing widespread outbreaks of deadly diseases, potentially leading to increased incidence of measles, pertussis, and other vaccine-preventable illnesses in under-vaccinated communities, especially given already declining childhood vaccination rates and recent measles outbreaks in multiple states. Health law experts such as Sara Rosenbaum, professor emerita at George Washington University, describe the strategy as sophisticated and opportunistic, noting that activists appear emboldened by having an ally in the HHS secretary’s office and are pursuing a broad default of no requirements, despite strong scientific consensus on the safety and efficacy of childhood vaccines in preventing morbidity and mortality. The coalition’s approach includes introducing bills in both politically favorable Republican-leaning states and unlikely Democratic strongholds like New York to demonstrate momentum and pressure lawmakers, while framing the issue as one of personal medical freedom and parental rights rather than rejection of vaccines outright. Critics argue the push overlooks historical evidence that school mandates have been instrumental in achieving and sustaining high coverage levels necessary for herd immunity, with exemptions already contributing to pockets of vulnerability that fuel outbreaks. The article highlights the contrast between the coalition’s growing organizational coordination and the longstanding public health framework upheld by state legislatures, federal agencies, and medical organizations that view mandates—with medical, religious, and philosophical exemptions in many jurisdictions—as a balanced mechanism to protect both individual children and community health.
Texas Attorney General Takes Dr. Mary Talley Bowden’s Side Against Texas Medical Board (Video)Texas Attorney General Ken Paxton intervened in a legal dispute on February 12, 2025, filing an Original Petition in Intervention in Travis County district court on behalf of the State of Texas to support Dr. Mary Talley Bowden against the Texas Medical Board (TMB), refusing to defend the TMB and instead seeking to have its public reprimand against her declared void as a matter of law. Paxton stated on X that he was intervening to protect Dr. Bowden’s lawful medical freedoms, accusing the TMB of acting out of personal animosity and spite rather than following published protocols or state laws, in violation of the Texas Constitution and U.S. Constitution. The reprimand stemmed from Dr. Bowden’s October 2021 prescription of ivermectin to a critically ill COVID-19 patient after the patient’s family obtained a Temporary Injunction requiring a Houston hospital to grant her emergency privileges for treatment; although an appeals court later stayed the injunction, Dr. Bowden asserted she was never notified of the stay. The state’s petition contends the sanction is invalid due to the absence of required medical expert testimony, improper labeling of her conduct as intentional despite her reliance on a court order and legal advice, inclusion of unsupported aggravating factors, and baseless speculation about potential future repetition of the conduct. It further alleges due process violations, including the TMB’s provision of a non-functional link for remote attendance at the sanctions hearing and refusal to correct the error before proceeding to a vote. The intervention aims to safeguard Texas citizens from improper TMB conduct, uphold state laws, and prevent irreparable harm to state sovereignty, requesting the court void the reprimand and permanently prohibit further disciplinary action related to the incident. Dr. Bowden responded on X expressing gratitude to Paxton, describing the move as a victory for her and her patients, asserting that no one should face lawsuits for seeking a second opinion, hospitals should comply with court orders, and physicians should not be targeted for aiding patients, while noting Texas has been influenced by a “medical mafia” but viewing this as progress toward accountability. The case remains pending in the 419th Judicial District Court in Travis County, representing a significant development where the State of Texas aligns against its own medical regulatory body in defense of a physician’s actions during the COVID-19 period.
Banning Pharma Advertising Won’t Make America Healthy Again Direct-to-consumer (DTC) pharmaceutical advertising should not be banned or arbitrarily restricted because it enhances patients’ access to medical information, increases awareness of potentially life-saving treatments, promotes appropriate prescription requests for underused therapies, and improves perceived quality of interactions with prescribers, according to a comprehensive review of evidence cited in the article. As a wife and mother, the author finds the Make America Healthy Again (MAHA) movement’s emphasis on personal responsibility, exercise, and balanced diets promising but expresses deep concern over aspects promoting greater government control in daily lives, arguing that families deserve more freedom and choice in decisions about medications and foods without interference from unelected bureaucrats in Washington. Under HHS Secretary Robert F. Kennedy Jr.’s leadership, the FDA has issued warning letters to pharmaceutical companies for allegedly misleading ads, such as one targeting Fasenra for asthma that depicted a woman as bored and homebound before treatment versus socially active with salsa dancing after, implying improvements in social and emotional functioning. This regulatory crackdown aligns with proposed legislation like the End Prescription Drug Ads Now Act (S.2068) introduced by Senators Bernie Sanders and Angus King in June 2025, which would prohibit DTC advertising of FDA-approved pharmaceuticals across television, radio, print, digital platforms, and social media while exempting medical devices, dietary supplements, cosmetics, and over-the-counter drugs. The article contends that such prohibitions or restrictions harm patients by limiting their ability to learn about drug options beyond those physicians may know or prefer to prescribe, particularly disadvantaging smaller, newer, or generic manufacturers whose products might otherwise remain obscure, potentially reducing market competition and leading to higher drug costs. DTC ads are already subject to extensive FDA regulation requiring them to reflect approved product labels, highlight benefits, maintain transparency standards, and include detailed risk discussions, enabling informed decision-making when these rules are followed. Proposed bans raise serious constitutional issues, as prescription drug advertising qualifies as protected commercial speech under the First Amendment, with overly broad restrictions risking a slippery slope toward broader censorship across industries and individuals. While acknowledging the need for providers to counter any mistaken patient impressions about medications, the piece asserts that transparency, open discourse, and patient education are essential for public health, and restricting information access would foster mistrust and poorer outcomes. Policymakers should reject such bans to prioritize patients and families, emphasizing that making America healthier begins with individual choices rather than political dictates. The author, Christina Smith, Director of the Taxpayer Protection Alliance’s Consumer Center, concludes that DTC advertising plays a critical role in informing patients and fostering competition in the medical marketplace when properly regulated.
Consciousness exists BEYOND death, bombshell study claims – as researcher argues the idea of dying should be ‘renegotiated’ A large-scale review of dozens of studies on near-death experiences, electrical brain activity in dying patients, and conscious awareness during cardiac arrest suggests that consciousness can persist beyond the point when the brain stops functioning and the heart ceases beating, challenging the conventional definition of death as the irreversible cessation of brain and circulatory activity and proposing instead that dying is a gradual, potentially interruptible process that should be “renegotiated” in medical, philosophical, and ethical contexts. Anna Fowler, a researcher from Arizona State University, presented the findings at the American Association for the Advancement of Science conference in Phoenix, arguing that death unfolds over minutes to hours as a “shifting landscape where consciousness, biology, and meaning persist longer than we once imagined,” with neural and biological functions declining gradually rather than ending instantaneously. The review highlights that 20% of heart attack survivors recall vivid conscious experiences during periods of clinical death when brain activity was absent, including perceptions of events around them despite no measurable brain function. Brain recordings from dying humans and animals document surges of electrical activity exceeding normal waking levels, while laboratory experiments show that metabolism, brain activity, and blood flow can be restored in mammal brains and organs well beyond traditional time limits for irreversible death. Fowler referenced related work by Dr. Sam Parnia of NYU Langone School of Medicine, whose research documented spikes in brain waves linked to higher cognitive functions like thinking, memory, and awareness persisting up to 60 minutes into CPR after cardiac arrest, with some revived patients accurately describing conversations and events in the room during their clinical death. These observations indicate that elements of consciousness may briefly continue beyond detectable brain signals, potentially influencing decisions around resuscitation timing, organ donation windows, and end-of-life care. Fowler emphasized the need for humility in approaching death, suggesting that the boundary is more fluid than previously assumed and that emerging evidence warrants redefining it as a negotiable condition rather than an absolute endpoint. The article frames the review as a “bombshell” challenge to long-held views, noting implications for how society understands the dying process and what, if anything, persists after clinical death, though it does not include specific patient anecdotes beyond aggregated data or direct criticisms of the claims.Question of The Day!
Hi Robert,
I know that you only recommend Sovereign Silver for your Silver Aloe Protocol and not homemade colloidal silver because of the particle size difference. Are you familiar with The Silver Edge’s particle size and ppm claims?
My husband has some acute intestinal infection that caused bleeding and mucus and we wanted to do your protocol, but we’re wondering if (because the particle size is almost as small as Sovereign Silver’s) if it would be ok to substitute it?
Sovereign Silver’s
suspended silver
particles are as small
as 0.8 nanometers.
The info for the silver that I make with The Silver Edge’s colloidal silver generator, they claim is approximately 7-10 ppm in concentration, with silver particles as low as 1nm in size.
Do you think that would be safe since it’s so small too?
We were wondering if we could substitute it to save money?
Michele
Remember Friends, The Power to Heal is Yours!
